← FDA DRUG APPROVALS

FDA ANDA · ANDA206572

DIFLORASONE DIACETATE

Sponsor: SCIEGEN PHARMS

APPLICATION
ANDA206572
TYPE
ANDA
ORIGINAL APPROVAL
2015-07-24
LATEST ACTION
2015-07-24
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

DIFLORASONE DIACETATEDiscontinued
DIFLORASONE DIACETATE 0.05% · OINTMENT · TOPICAL

Approval history

2015-07-24UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →